These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21920921)

  • 1. Exacerbation phenotyping in chronic obstructive pulmonary disease.
    Hurst JR
    Am J Respir Crit Care Med; 2011 Sep; 184(6):625-6. PubMed ID: 21920921
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic obstructive pulmonary disease exacerbation by corynebacterium propinquum.
    Prats-Sánchez I; Soler-Sempere MJ; Sánchez-Hellín V
    Arch Bronconeumol; 2015 Mar; 51(3):154-5. PubMed ID: 25282710
    [No Abstract]   [Full Text] [Related]  

  • 3. Serological evidence of acute infection with the Chlamydia-like microorganism Simkania negevensis (Z) in acute exacerbation of chronic obstructive pulmonary disease.
    Lieberman D; Dvoskin B; Lieberman DV; Kahane S; Friedman MG
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):307-9. PubMed ID: 12072944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ralstonia picketti in chronic obstructive pulmonary disease exacerbation].
    Sancho-Chust JN; Andreu AL; Chiner E
    Arch Bronconeumol; 2010 Jan; 46(1):47-8. PubMed ID: 19656611
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of antibiotics in the exacerbation of chronic obstructive pulmonary disease].
    Alvarez F; Bouza E; García-Rodríguez JA; Mayer MA; Mensa J; Monsó E; Nodar E; Picazo JJ; Sobradillo V; Torres A
    Rev Esp Quimioter; 2001 Mar; 14(1):87-96. PubMed ID: 11376355
    [No Abstract]   [Full Text] [Related]  

  • 6. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
    Sethi S; Evans N; Grant BJ; Murphy TF
    N Engl J Med; 2002 Aug; 347(7):465-71. PubMed ID: 12181400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation phenotyping in chronic obstructive pulmonary disease.
    MacDonald M; Korman T; King P; Hamza K; Bardin P
    Respirology; 2013 Nov; 18(8):1280-1. PubMed ID: 24164687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of airway inflammation by Haemophilus influenzae isolates associated with chronic obstructive pulmonary disease exacerbation.
    Look DC; Chin CL; Manzel LJ; Lehman EE; Humlicek AL; Shi L; Starner TD; Denning GM; Murphy TF; Sethi S
    Proc Am Thorac Soc; 2006 Aug; 3(6):482-3. PubMed ID: 16921118
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe acute exacerbation of chronic obstructive pulmonary disease: when are multiple-drug-resistant bacteria the culprits?
    Epstein SK
    Crit Care Med; 2006 Dec; 34(12):3047-8. PubMed ID: 17130702
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of Streptococcus pneumonia and Haemophilus influenza in acute exacerbation of chronic obstructive airway disease and their sensitivity to levofloxacin.
    Furqan S; Paracha SA
    J Pak Med Assoc; 2014 Apr; 64(4):399-402. PubMed ID: 24864632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiogram pattern of Moraxella catarrhalis isolates in acute exacerbation chronic obstructive pulmonary disease.
    Christol TJ; Shankar EM; Rao UA
    Chemotherapy; 2011; 57(1):94-6. PubMed ID: 21346354
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacterial exacerbations of chronic obstructive pulmonary disease. The role of lung function in aetiology of exacerbation.
    Kieszko R; Szmygin-Milanowska K; Chudnicka A; Gołebiowska I; Łagozna J; Milanowski J
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):475-80. PubMed ID: 15315034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exacerbation phenotyping in chronic obstructive pulmonary disease].
    Feng Y; Ou X; Tang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Apr; 37(4):241-4. PubMed ID: 24969708
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bacteriology in acute exacerbation in patients hospitalized frequently for acute exacerbation of chronic obstructive pulmonary disease].
    Guo Z; Chang C; Chen Y; Zheng Y; Yao W
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):729-32. PubMed ID: 24844953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?
    Sethi S
    Proc Am Thorac Soc; 2004; 1(2):109-14. PubMed ID: 16113422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
    Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
    Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease].
    Niu YM; Tong ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Apr; 32(4):295-7. PubMed ID: 19576046
    [No Abstract]   [Full Text] [Related]  

  • 19. Airway bacterial colonization and serum C-reactive protein are associated with chronic obstructive pulmonary disease exacerbation following bronchoscopic lung volume reduction.
    Fruchter O; Rosengarten D; Goldberg E; Ben-Zvi H; Tor R; Kramer MR
    Clin Respir J; 2016 Mar; 10(2):239-45. PubMed ID: 25196428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
    Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
    Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.